Clinical Trial Update: Ketamine Sickle Cell Disease [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating ketamine for sickle cell disease and chronic pain has been withdrawn from the study list.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pain
• Sickle Cell Disease

Drugs mentioned

• Ketamine (ketamine)

Snippet

Sponsor: University of South Florida | Conditions: SC Disease, Pain, Chronic | Phase 3 | Status: WITHDRAWN